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Targeted fluorescence imaging enhanced by 2D 
materials: A comparison between 2D MoS2 and 
graphene oxide 
Donghao Xie,a1 Ding-Kun Ji,b1 Yue Zhang,bc Jun Cao,a Hu Zheng,a Lin Liu,a Yi Zang,c Jia 
Li,c* Guo-Rong Chen,b Tony D Jamesd* and Xiao-Peng Heb* 
 
Here we demonstrate that 2D MoS2 can enhance the receptor-
targeting and imaging ability of a fluorophore-labelled ligand. 
The 2D MoS2 has an enhanced working concentration range 
when compared with graphene oxide, resulting in the improved 
imaging of both cell and tissue samples. 
Receptor proteins are a class of important transmembrane 
biomacromolecules that control a diverse range of physiological 
processes. While a number of selective receptor-ligand 
interactions are key to the initiation of downstream cellular 
pathways, many other types of receptors are responsible for the 
endocytosis, and thus clearance, of harmful molecules from the 
circulation in blood. Some receptor proteins located on the 
surface of cells can facilitate the invasion of pathogens, 
however.1 Recent studies have revealed an upregulation of 
carbohydrate receptors during inflammation and cancer 
metastasis.2 As a result, receptor proteins are promising 
biomarkers for targeted disease diagnosis and therapy.3-7 
Since the discovery of graphene which has demonstrated 
exceptional mechanical, optical and electrical properties, 
increasing efforts have been directed to the development of 
two-dimensional (2D) graphene analogues for application in a 
variety of research areas.8-12 In particular, recent literature has 
seen an extensive interest in the construction of diagnostic and 
therapeutic materials based on 2D transition metal 
dichalcogenides (TMDs).8-19 Compared to GO, the 2D TMDs are 
structurally more diverse, and some materials have proven to 
have a better biocompatibility for biological applications.11-13 
The 2D TMDs can be easily functionalized with a diverse 
range of biomolecules and drugs by supramolecular assembly 
for biosensing and cancer therapy.14-16 Owing to their intrinsic 
photothermal and photoacoustic properties, these TMDs have 
also been used for in vivo cancer theranostics.17-19 While these 
pioneering investigations have highlighted the promise of TMDs 
as a new generation of biomedical tools, evidence for the 
applicability of TMDs to targeted bio imaging has been elusive. 
 
Figure 1. (a) Structure of the fluorophore-tagged glycoligand (DK1) and cartoon of 
2D MoS2 and graphene oxide (GO). High-resolution transmission electron 
microscopy of (b) GO and (d) 2D MoS2. (c) Scanning electron microscopy of 2D 
MoS2. Dynamic light scattering of (e) 2D MoS2 and (f) GO. (g) Stacked UV-vis 
spectra of 2D MoS2 and GO. (h) Stacked Raman spectra of 2D MoS2 and GO. 
Here, we report an interesting observation that a 2D TMD 
(molybdenum disulfide, MoS2) drastically enhances the 
receptor-targeting and imaging ability of a fluorophore-labelled 
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ligand. The 2D MoS2 shows a much better working 
concentration range than GO, improving the imaging for both 
cellular and tissue samples. As shown in Fig. 1a, we used the 
glycoligand (galactose) for, the asialoglycoprotein carbohydrate 
receptor (ASGPr).20 The glycoligand was coupled to a red-
emitting dicyanomethylene-4H-pyran (DCM) fluorescent dye by 
an efficient click reaction, producing glycoprobe (DK1) capable 
of cellular imaging (Fig. 1a).21,22 Then, the receptor-targeting 
imaging ability of DK1 was investigated using both 2D MoS2 and 
GO (Fig. 1a). 
 
Figure 2. (a) Fluorescence imaging of Hep-G2 (human liver cancer) cells with DK1 
at two concentrations and fluorescence quantification of the cells with (b) 20 μM 
DK1 and (c) 40 μM DK1 in the absence and presence of increasing 2D MoS2 or 
graphene oxide (GO). Scale bar = 100 μm (applicable to all images). Exitation 
channel: 520-550 nm; emission: 580-650 nm. 
GO was produced using the modified Hummer’s method,5 
and 2D MoS2 was prepared using the recently established, 
simple liquid exfoliation method from commercial MoS2 
powder.23 The resulting 2D materials were characterized by a 
series of microscopic and spectroscopic techniques (Fig. 1). Fig 
1b, Fig. 1c and Fig. 1d show the high-resolution transmission 
electron microscope (HRTEM) image of GO, scanning electron 
microscope (SEM) image of 2D MoS2 and TEM image of 2D MoS2, 
respectively. The objects observed in these images appear to be 
thin flakes. Dynamic light scattering (DLS) suggested a similar 
size distribution for the 2D MoS2 (Fig. 1e) and GO (Fig. 1f) sheets. 
Moreover, typical UV-vis and Raman peaks were observed for 
both materials. While a characteristic broad UV absorbance 
band for GO was observed,24,25 and typical absorbance peaks at 
623 and 684 nm, assigned to the A1 and B1 direct exciton 
transitions of 2D MoS2, respectively, were observed.26-28 The 
typical D band (1350 cm-1) and G band (1595 cm-1) indicated the 
presence of GO sheets,5 whereas peaks centered at 404 and 378 
cm-1, which are the A1g (out-of-plane vibration of S) and E12g (in-
plane relative motion between S and Mo) modes of hexagonal 
MoS2, respectively, suggest the formation of 2D MoS2.29 In 
addition, the materials were also characterized using Zeta 
potential analysis (Fig. S1) and fluorescence spectroscopy (Fig. 
S2). The results indicate a negatively charged nature30,31 and 
weak intrinsic fluorescence emission of the 2D materials. 
 
Figure 3. Fluorescence imaging (a) and quantification (b) of Hep-G2 (human liver 
cancer), HeLa (human cervix cancer) and A549 (human lung cancer) cells with 10 
μM DK1 in the absence of 62.5 μg mL-1 2D MoS2. (c) Relative mRNA level of 
different cells determined by real-time quantitative polymerase chain reaction 
(***P<0.001; n. d. = not detectable). Scale bar = 100 μm (applicable to all images). 
Exitation channel: 520-550 nm; emission: 580-650 nm. 
With the fluorophore-labelled ligand and the 2D materials in 
hand, we performed cellular imaging assays. DK1 (at two 
different concentrations) with or without increasing amounts of 
2D MoS2 or GO were incubated with Hep-G2 (human liver 
cancer) cells that significantly express ASGPr20 for 15 min. 
Subsequently fluorescence images were recorded and the 
fluorescence intensities quantified (Fig. 2). As shown in Fig. 2a, 
while the fluorescence imaging effect of the DK1 alone was 
weak for Hep-G2, the presence of increasing 2D MoS2 drastically 
increased the fluorescence. We also observed that the presence 
of increasing GO did not enhance the fluorescence under similar 
imaging conditions. To quantify these results, the fluorescence 
intensities of the cell lines were measured (Fig. 2b and Fig. 2c). 
Similarly, the result indicate that the presence of increasing 2D 
MoS2 enhances the fluorescence of the cell lines (except for 40 
μM DK1 with 500 μg mL-1 2D MoS2, Fig. 2c). In contrast, the 
presence of increasing GO did not enhance the fluorescence. 
The only exception is the mixture of 40 μM DK1 with a small 
amount of GO (25 μg mL-1 and 50 μg mL-1).32 However, further 
increase of the GO concentration led to sharp fluorescence 
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quenching. This result suggests a better working concentration 
range for 2D MoS2 than GO. 
To test whether the fluorescence imaging is predominantly 
based on ASGPr-glycoligand interactions, we used a cervical 
cancer cell line (HeLa) and a lung cancer cell line (A549) without 
ASGPr expression as control.33-35 From both fluorescence 
imaging (Fig. 3a) and quantification (Fig. 3b) we determined that 
the fluorescence for both cells quickly reached equilibrium. 
Interestingly, over the whole time period, the material 
produced a stronger fluorescence with Hep-G2 than with HeLa 
and A549, suggesting that the enhancement was caused by 
ligand-ASGPr recognition events. Notably, the fluorescence 
imaging results were in good agreement with the ASGPr 
expression level of the cells, as determined by real-time 
quantitative polymerase chain reaction (RT-qPCR) (Fig. 3c). 
 
 
Figure 4. Fluorescence imaging of (a) xenograft section with 10 μM DK1 in the presence of increasing 2D MoS2, (b) xenograft section with 10 μM DK1 in the presence 
of increasing GO, (c) spleen section with 10 μM DK1 in the presence of increasing 2D MoS2 and (d) lung section with 10 μM DK1 in the presence of increasing 2D MoS2. 
Fluorescence quantification of (e) xenograft section with 10 μM DK1 in the presence of increasing 2D MoS2, (f) xenograft section with 10 μM DK1 in the presence of 
increasing GO and (g) different tissue sections in the presence of 500 μg mL-1 2D MoS2. (h) Relative mRNA level of different tissue sections determined by real-time 
quantitative polymerase chain reaction (***P<0.001). Scale bar = 100 μm (applicable to all images). Exitation channel: 520-550 nm; emission: 580-650 nm. 
Subsequently, we used tissue samples to investigate the 
imaging properties of the 2D materials. A female athymic 
BALB/c nu/nu mouse with a Hep-G2-bearing xenograft was 
used.32 The collected tissue sections were the xenograft and 
two healthy organs, the spleen and the lung. We determined 
that with an increasing concentration of 2D materials, the 
fluorescence of DK1 gradually increased with xenograft section 
in the presence of 2D MoS2 (Fig. 4a and Fig. 4e), but not for GO 
(Fig. 4b and Fig. 4f). In addition, a fluorescence increase was not 
observed for the spleen (Fig. 4c and Fig. 4g) or lung sections (Fig. 
4d and Fig. 4g), which were shown to hardly express ASGPr by 
RT-qPCR (Fig. 4h). 
In summary, we have demonstrated that 2D MoS2 can 
significantly enhance the fluorescence imaging ability of 
fluorophore-labelled ligand molecules for transmembrane 
receptors in a concentration dependent manner. Compared to 
GO, a 2D carbon material widely used for biosensing and 
bioimaging, the working concentration range for the 2D MoS2 
was significantly improved. This research suggests that 2D 
materials with similar morphology but different chemical 
components might function differently at certain cellular 
interfaces. This study may also provide insight into the 
development of other effective low-dimensional materials for 
targeted theranostics.36-39 
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